Immunovant Inc. Common Stock vs Roundhill NVDA WeeklyPay ETF — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Roundhill NVDA WeeklyPay ETF trades at $37.8 (market cap $123.47M). The key difference: Immunovant Inc. Common Stock is far larger — about 53.6× Roundhill NVDA WeeklyPay ETF's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Roundhill NVDA WeeklyPay ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Roundhill NVDA WeeklyPay ETF for 50 Days on average.
| IMVT | NVDW | |
|---|---|---|
Market Cap | $6.62B | $123.47M |
Volume | 1,131,364 | 50,701 |
Sector | Health | Income / Options Overlay |
52-Week High | $44.96 | $52.33 |
52-Week Low | $17.03 | $31.88 |
Typical Hold Time | 0 Days | 50 Days |
Enterprise Value | $5.72B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →NVDW is an actively managed ETF that seeks to provide weekly distributions and returns equal to 1.2 times (120%) the calendar week performance of Nvidia (NVDA) common shares. It combines modest leverage with a high-frequency payout schedule, designed for investors who want amplified exposure to Nvidia alongside a consistent weekly income stream.
Read more on NVDW →